Association of antibiotics with Stevens–Johnson syndrome and toxic epidermal necrolysis: A real-world pharmacovigilance study
Authors:
- 25 April 2025
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 66 (2) , 107524
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hunan Province (2023JJ60513)
This publication has 27 references indexed in Scilit:
- Human Leukocyte Antigens and Sulfamethoxazole/Cotrimoxazole–Induced Severe Cutaneous Adverse ReactionsJAMA Dermatology, 2024
- High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysisThe American Journal of Emergency Medicine, 2024
- Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisJAMA Dermatology, 2023
- Clinical features and prognostic factors of severe cutaneous adverse drug reactions: A single-center retrospective study of 209 cases in ChinaInternational Immunopharmacology, 2022
- Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactionsDrug Metabolism and Pharmacokinetics, 2022
- Drug allergy and autoimmune diseasesAllergology International, 2022
- Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020Drug Safety, 2021
- Human leukocyte antigen and idiosyncratic adverse drug reactionsDrug Metabolism and Pharmacokinetics, 2017
- Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse ReactionsJAMA, 2014
- Performance of Probabilistic Method to Detect Duplicate Individual Case Safety ReportsDrug Safety, 2014